Urethral Neoplasms

This means a growth, like a tumor or cancer, in the urethra. The urethra is the tube that carries urine from the bladder out of the body. While rare, urethral cancer can occur.

Condition

What people with Urethral Neoplasms report

Every report comes from a Lived member, sent anonymously.

Have you tried Radiation Therapy for Urethral Neoplasms?

NameHow it went

About Urethral Neoplasms

What It Is

Urethral neoplasms are growths in the urethra, the tube that carries urine from the bladder out of the body. The term covers both noncancerous growths and urethral cancer, but the one that matters most is cancer, a rare disease in which malignant cells form in the lining of the urethra or the glands around it. It is more common in men than in women and is usually found in people over 60. The urethra is about 1.5 inches long in women, sitting just above the vagina, and about 8 inches long in men, running through the prostate and penis. Where along that tube a cancer starts shapes almost everything that follows. Cancers near the opening (the distal urethra) tend to be found earlier and are easier to treat. Cancers closer to the bladder (the proximal urethra) have usually grown more deeply by the time they are found. Early urethral cancer may cause no symptoms. When symptoms appear, they often involve blood in the urine or bleeding from the urethra, a weak or stop-and-go urine stream, trouble starting to urinate, needing to urinate often at night, leaking, or discharge. Some people notice a lump or thickening in the area between the genitals and anus, along the penis, or in the groin. Because these symptoms are common to many minor problems, urethral cancer is often diagnosed late. Urethral cancers are named for the cell type they start in: urothelial (also called transitional cell) carcinoma, squamous cell carcinoma and adenocarcinoma. Urothelial cancer is the most common type in men, while adenocarcinoma is relatively more common in women. A tumor found in the urethra is also often cancer that has spread there from the bladder, which is treated as bladder cancer.

Causes & Risk Factors

Most of what is known about the causes of urethral cancer comes from small groups of patients, because the disease is so rare. Long-term irritation and inflammation of the urethra seem to be the common thread. In men, this includes a long-standing narrowing of the urethra (a stricture), repeated use of catheters, injury, and infections such as human papillomavirus (HPV, especially type 16) and other sexually transmitted infections. In women, a urethral diverticulum (a small pouch off the urethra) and frequent urinary tract infections are linked to higher risk. A history of bladder cancer also raises the risk, and in men, cancer in the part of the urethra that passes through the prostate can appear at the same time as bladder or prostate cancer, or later. Past radiation to the pelvis is another predisposing factor. Having a risk factor does not mean someone will develop urethral cancer, and many people who do have none of these known factors.

How It's Diagnosed

Evaluation starts with a physical exam of the genitals and groin, looking and feeling for lumps or enlarged lymph nodes. Men usually have a rectal exam, and women a pelvic exam with gentle feeling along the urethra. Urine tests can show blood or infection, and urine cytology looks for cancer cells under a microscope. Cytology misses a substantial share of urethral cancers, so a normal result does not rule it out. The key test is looking inside the urethra and bladder with a thin lighted scope (urethrocystoscopy, often done under anesthesia) and taking a biopsy, a small tissue sample examined for cancer. The scope also checks for tumors elsewhere in the bladder and urinary tract. In women, several noncancerous problems, such as a caruncle (a small fleshy growth at the urethral opening), prolapse of the urethral lining, cysts or a diverticulum, can cause similar bleeding or urinary symptoms, and the exam and biopsy help tell these apart from cancer. If cancer is confirmed, staging shows how far it has grown. Magnetic resonance imaging (MRI) of the pelvis shows how deeply the tumor has invaded and whether nearby lymph nodes are involved, and a computed tomography (CT) scan of the chest, abdomen and pelvis, or sometimes a positron emission tomography (PET) scan, looks for spread to other parts of the body. The stage, the location in the urethra and the cell type together guide treatment.

Treatment Options

Treatment depends mainly on where in the urethra the cancer sits, how deeply it has grown, whether it has spread, and the person's sex and overall health. Because urethral cancer is rare, it is worth being treated by a team experienced with it, often at a specialist cancer center, where surgeons, radiation oncologists and medical oncologists plan care together. Small, shallow tumors near the opening can often be removed with organ-sparing approaches. Options include cutting the tumor out through the urethra, removing only the affected section of the urethra, or burning it away with an electric current or laser. These preserve urination and sexual function, but superficial removal alone carries a meaningful chance of the cancer returning, so close follow-up matters. In women, internal radiation (brachytherapy, where a radiation source is placed in or next to the tumor), sometimes with external radiation, is an alternative to surgery for early distal tumors. Deeper or proximal tumors usually need more extensive treatment. In men this can mean removing part or all of the penis, or removing the bladder and prostate along with the urethra. In women it can mean removing the urethra, bladder and front wall of the vagina (anterior exenteration). Nearby lymph nodes are often removed too. When the urethra or bladder is removed, the surgeon creates a new route for urine (urinary diversion), either a stoma on the belly that drains into a bag worn under clothing or an internal pouch emptied through a catheter. These operations can control the cancer but have major effects on body image, sexual function and daily life, and more than half of men in reported series have erectile problems afterward. Radiation therapy, often combined with chemotherapy that makes cancer cells more sensitive to radiation, is an alternative that can preserve the penis or vagina for some people, including those with locally advanced squamous cell cancer and those who cannot have or do not want radical surgery. Surgery can still be used afterward if cancer remains or returns. Radiation can later cause scarring and narrowing of the urethra. For proximal tumors that have grown deeper, chemotherapy containing cisplatin is often given before surgery to shrink the tumor and improve results. When the cancer has spread to distant parts of the body, platinum-based chemotherapy is the main treatment, and immunotherapy drugs that help the immune system attack cancer, used as they are in bladder cancer, are an emerging option. Radiation can relieve pain or bleeding from spread. Because large studies are not possible in so rare a cancer, much of this guidance rests on smaller case series, and clinical trials are a reasonable option to ask about at any stage.

What to Expect

The outlook for urethral cancer varies widely. Overall, a little over half of people are alive five years after diagnosis, but people with small tumors near the opening generally do much better than those whose cancer started close to the bladder or had already spread to lymph nodes. Age, tumor size, cell type and whether the bladder or prostate is also involved all affect the outlook. Recovery depends heavily on the treatment. Organ-sparing procedures usually allow a return to normal urination, though some people develop narrowing of the urethra that needs further treatment. After radical surgery, people learn to care for a stoma or catheterize an internal pouch, and adjusting to changes in sexual function and body image can take time. Specialized nurses, pelvic floor and sexual health services, and reconstructive surgery in some cases can help. Radiation can cause bladder irritation and burning with urination during treatment, and late scarring months or years later. Urethral cancer can come back in the urethra or elsewhere, most often in the first two years. Follow-up typically includes exams, scope checks of the urethra and bladder, urine cytology and imaging every 3 to 6 months for the first two years, then yearly, adjusted to the original stage and treatment. People who had their bladder removed for bladder cancer but kept their urethra may also have the urethra checked regularly for new cancer.

When to Seek Help

See a clinician if you notice blood in your urine or bleeding from the urethra, a lump or thickening along the penis, near the urethral opening or between the genitals and anus, a painless swelling in the groin, or a urine stream that becomes weak, interrupted or hard to start and stays that way. These are usually caused by something other than cancer, but they deserve an exam, and a scope examination if they persist. People who have had bladder cancer should report any new bleeding or urinary change promptly. During or after treatment, contact your care team about new bleeding, a new lump in the groin, or a urine stream that is steadily getting narrower, since these can signal recurrence or a stricture. Being completely unable to pass urine, especially with a painful, swollen lower belly, needs medical care right away, because a blocked bladder has to be drained.

Questions to Ask Your Doctor

  1. 1.Where in the urethra is the tumor, what type of cancer is it, and has it spread to lymph nodes or elsewhere?
  2. 2.Which treatments are realistic for my stage, and could radiation or organ-sparing surgery work as well as radical surgery for me?
  3. 3.How would each option affect how I urinate and my sexual function, and what support is available if I need a urinary diversion?
  4. 4.Is there a specialist center or clinical trial with more experience treating urethral cancer that I should consider?
  5. 5.What follow-up schedule will I need, and which symptoms should prompt me to call between visits?

Last reviewed • Oct 2026

Educational content, not medical advice.